palladium has been researched along with Prostatic Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kal, HB; Van Gellekom, MP | 1 |
| Bice, WS; Kiefer, EJ; Prestidge, BR; Prete, JJ | 1 |
| Corn, BW; Dicker, AP; Waterman, FM; Yue, N | 1 |
| Corn, BW; Dicker, AP; Nath, R; Waterman, FM; Yue, N | 1 |
| Dicker, AP; Waterman, FM | 1 |
| Chen, Z; Dicker, AP; Nath, R; Peschel, R; Waterman, FM; Yue, N | 1 |
| Chen, Z; Nath, R; Peschel, R; Roberts, KB; Wang, X; Yue, N | 1 |
| Battermann, JJ; Kal, HB; Moerland, MA; Van Gellekom, MP | 1 |
| Dogan, N; Flanigan, RC; Glasgow, GP; Keys, K; Mohideen, N | 1 |
9 other study(ies) available for palladium and Prostatic Diseases
| Article | Year |
|---|---|
How low is the alpha/beta ratio for prostate cancer?
Topics: Brachytherapy; DNA Repair; Edema; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Reference Values; Relative Biological Effectiveness | 2003 |
Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Topics: Adenocarcinoma; Brachytherapy; Dose-Response Relationship, Radiation; Edema; Humans; Iodine Radioisotopes; Male; Neoplasm Staging; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 1998 |
Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radiography; Radiotherapy Dosage; Time Factors | 1998 |
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Movement; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Time Factors; Tomography, X-Ray Computed | 1999 |
Effect of post-implant edema on the rectal dose in prostate brachytherapy.
Topics: Brachytherapy; Cohort Studies; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Prostatic Diseases; Prostatic Neoplasms; Radiation Dosage; Radiopharmaceuticals; Rectum; Tomography, X-Ray Computed | 1999 |
Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Topics: Brachytherapy; Edema; Half-Life; Humans; Iodine Radioisotopes; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Time Factors | 1999 |
Dosimetric effects of edema in permanent prostate seed implants: a rigorous solution.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Models, Biological; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage | 2000 |
Biologically effective dose for permanent prostate brachytherapy taking into account postimplant edema.
Topics: Algorithms; Brachytherapy; Edema; Gold Radioisotopes; Half-Life; Humans; Iodine Radioisotopes; Linear Models; Male; Palladium; Prostate; Prostatic Diseases; Prostatic Neoplasms; Radioactivity; Radioisotopes; Relative Biological Effectiveness; Time Factors | 2002 |
Effect of prostatic edema on CT-based postimplant dosimetry.
Topics: Brachytherapy; Edema; Humans; Iodine Radioisotopes; Male; Palladium; Physical Phenomena; Physics; Prostatic Diseases; Prostatic Neoplasms; Radioisotopes; Radiotherapy Dosage; Rectum; Tomography, X-Ray Computed; Urinary Bladder | 2002 |